349 |
i2 Late-Breaking Clinical Trials Highlights |
Ted Feldman |
Jul. 27. 07 |
348 |
Special Techniques for CTOs |
Yasushi Asakura |
Jul. 20. 07 |
347 |
CTO: Is It Worth the Effort? Show Me the Data |
Barry D. Rutherford |
Jul. 20. 07 |
346 |
Chronic Coronary Total Occlusion |
Etsuo Tsuchikane |
Jul. 20. 07 |
345 |
DES in CTO |
Charles Chan |
Jul. 20. 07 |
344 |
New Devices and Techniques for Chronic Total Occlusions: The Safe-Cross Wire and Other Guided Systems |
Charles A. Simonton |
Jul. 20. 07 |
343 |
Drug Eluting Stent- The Beginning of the End or the End of the Beginning |
Patrick W. Serruys |
Jul. 20. 07 |
342 |
Contemporary Therapy of Bifurcation Lesions |
Angela Hoye |
Jul. 13. 07 |
341 |
DES Safety in Bifurcation Lesions |
Thierry Lefevre |
Jul. 13. 07 |
340 |
An Integrated Approach to Bifurcation Lesions: Lessons From Years of Randomized Trials, Registries, Debates, and "Mature Thinking" |
Antonio Colombo |
Jul. 13. 07 |